| Market Capitalization (Millions $) |
- |
| Shares
Outstanding (Millions) |
484 |
| Employees |
250 |
| Revenues (TTM) (Millions $) |
- |
| Net Income (TTM) (Millions $) |
-260 |
| Cash Flow (TTM) (Millions $) |
-682 |
| Capital Exp. (TTM) (Millions $) |
2 |
Business Description
Eqrx Inc is a biotech company that specializes in developing and commercializing innovative therapies aimed at improving quality of life for patients globally, primarily focused on oncology, immunology, and neuroscience. The company was founded in 2020 by Alexis Borisy, who is also the CEO, with the aim of creating a new model for drug development and commercialization that is more efficient and affordable compared to traditional pharmaceutical companies.
The company's unique business model combines a technology-based approach with a patient-centric focus to identify and develop therapies that provide the most significant benefit to patients. The company has built an extensive network of industry experts, entrepreneurs, and investors to ensure that it remains at the forefront of innovation in the biotech industry.
Eqrx has a pipeline of promising drug candidates, including EGFR inhibitor, BTK inhibitor, and CD19 CAR-T cell therapies. The company is also developing small molecules for the treatment of autoimmune diseases and has several other preclinical programs underway.
The company's decentralized model of drug development involves a team-based approach with distributed centers of excellence that allows for a rapid and cost-effective development of therapeutic products. This approach eliminates the high overhead costs of traditional pharmaceutical companies, making drug products developed by Eqrx more affordable for patients.
Eqrx has established partnerships with other leading biotech companies and academia to leverage the best available technology and expertise. The company has also attracted top talent from the biotech industry, including scientists, physicians, and drug developers, to work on its innovative projects.
In summary, Eqrx is a rapidly growing biotech company with a unique approach to drug development aimed at creating innovative, affordable, and impactful therapies to enhance the quality of life for patients. The company's decentralized model, cutting-edge technology, and patient-centric focus have set it apart from traditional pharmaceutical companies, making Eqrx a leading force in the biotech industry.
Company Address: 50 Hampshire Street Cambridge 2139 MA
Company Phone Number: 315-2255 Stock Exchange / Ticker: NASDAQ EQRX
|
%
3.02% 